These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 26354852)
1. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis. Tang Y; Yan G; Song X; Wu K; Li Z; Yang C; Deng T; Sun Y; Hu X; Yang C; Bai H; Li H; Tan W; Ye M; Liu J J Cell Mol Med; 2015 Dec; 19(12):2806-17. PubMed ID: 26354852 [TBL] [Abstract][Full Text] [Related]
2. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo. Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression. Sun Y; Yang C; Chen J; Song X; Li Z; Duan M; Li J; Hu X; Wu K; Yan G; Yang C; Liu J; Tan W; Ye M J Cell Mol Med; 2016 Apr; 20(4):698-709. PubMed ID: 26849396 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072 [TBL] [Abstract][Full Text] [Related]
5. Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma. Won KJ; Im JY; Yun CO; Chung KS; Kim YJ; Lee JS; Jung YJ; Kim BK; Song KB; Kim YH; Chun HK; Jung KE; Kim MH; Won M Int J Cancer; 2014 Jun; 134(11):2595-604. PubMed ID: 24214091 [TBL] [Abstract][Full Text] [Related]
6. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
8. Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway. Wu L; Zhang G; Zhu Q; Huang Y J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583438 [TBL] [Abstract][Full Text] [Related]
9. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974 [TBL] [Abstract][Full Text] [Related]
10. Induction of G2/M Cell Cycle Arrest via p38/p21 Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594 [TBL] [Abstract][Full Text] [Related]
11. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
14. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R. Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345 [TBL] [Abstract][Full Text] [Related]
16. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling. Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918 [TBL] [Abstract][Full Text] [Related]
18. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
19. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling. Xu X; Jiang J; Yao L; Ji B Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer. Lin Z; Xiong L; Lin Q Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]